Ocular Therapeutix, Inc. (OCUL) vs Pharvaris N.V. (PHVS)
Ocular Therapeutix, Inc. and Pharvaris N.V. are both Biotechnology companies. Ocular Therapeutix, Inc. and Pharvaris N.V. are of similar size ($2.3B and $2.2B). Pharvaris N.V. has the higher net margin (0.00% vs −579.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Pharvaris N.V. leads on 8 and Ocular Therapeutix, Inc. on 5.
Valuation
Profitability
| Metric | OCUL | PHVS | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.11% | 0.00% | 65.16% |
| Operating margin | (603.04%) | 0.00% | 0.00% |
| Net margin | (579.10%) | 0.00% | 0.00% |
| Free cash flow margin | (490.07%) | 0.00% | 0.00% |
| Return on equity | (72.99%) | (71.50%) | (57.72%) |
| Return on assets | (53.70%) | (64.43%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack